Distribution of α2-adrenoceptor mRNAs in the rat lumbar spinal cord in normal and axotomized rats

NeuroReport

Volumn 10, Issue 13, 1999, Pages 2835-2839

  Shi, Tie Jun Sten ^c   Winzer Serhan, Ursula ^a,b   Leslie, Frances ^a   Hokfelt T ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE

Author keywords

Dorsal horn; In situ hybridization; Motoneurons; Nerve injury; Noradrenaline

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; MESSENGER RNA; ALPHA ADRENERGIC RECEPTOR; ISOPROTEIN;

ANIMAL TISSUE; ARTICLE; IN SITU HYBRIDIZATION; LABELING INDEX; LUMBAR SPINAL CORD; MOTONEURON; NERVE FIBER TRANSECTION; NERVE INJURY; NOCICEPTION; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; RNA PROBE; SCIATIC NERVE; SPINAL CORD VENTRAL HORN; TISSUE DISTRIBUTION; ANIMAL; BACK; CYTOLOGY; GENETICS; MALE; METABOLISM; NERVE CELL; REFERENCE VALUE; SPINAL CORD; SPRAGUE DAWLEY RAT;

ANIMALS; AXOTOMY; IN SITU HYBRIDIZATION; LUMBOSACRAL REGION; MALE; NEURONS; PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA; REFERENCE VALUES; RNA, MESSENGER; SPINAL CORD; TISSUE DISTRIBUTION;

EID: 0033538907     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199909090-00025     Document Type: Article

References (33)

1. Carlsson A, Falck B, Fuxe K and Hillarp N-Ā. Acta Physiol Scand 60, 112-119 (1964).
2. Dahlström A and Fuxe K. Experientia 20, 398-399 (1964).
3. Westlund KN, Bowker RM, Ziegler MG and Coulter JD. Descending noradrenergic projections and their spinal terminations. In: Kuypers HGJM and Martin GF, eds. Descending Pathways to the Spinal Cord. Progress in Brain Research. Amsterdam: Elsevier, 1982: 219-238.
4. Jones DJ, Kendall DE and Enna SJ. Neuropharmacology 21, 191-195 (1982).
5. Howe JR and Yaksh TL. Eur J Pharmacol 106, 547-559 (1984).
6. Sullivan AF, Dashwood MR and Dickenson AH. Eur J Pharmacol 138, 169-177 (1987).
7. Simmons RMA and Jones DJ. Brain Res 445, 338-449 (1988).
8. Giroux N, Rossignol S and Reader TA. J Comp Neurol 406, 402-414 (1999).
9. Yaksh TL. Pharmacol Biochem Behav 22, 845-58 (1985).
10. Uhlén S, Persson ML, Alari L et al. J Neurochem 55, 1905-1914 (1990).
11. Rawlow A and Gorka Z. J Neural Transm 66, 93-105 (1986).
12. Tanabe M, Ono H and Fukuda H. Jpn J Pharmacol 54, 69-77 (1990).
13. Bylund DB, Eikenberg DC, Hieble JP et al. Pharmacol Rev 46, 121-136 (1994).
14. Nicholas AP, Hökfelt T and Pieribone VA. Trends Pharmacol Sci 17, 245-254 (1996).
15. McCune SK, Voigt MM and Hill JM. Neuroscience 57, 245-255 (1993).
16. Nicholas AP, Pieribone V and Hökfelt T. J Comp Neurol 328, 575-594 (1993).
17. Smith MS, Schambra UB, Wilson KH et al. Brain Res Mol Brain Res 34, 109-117 (1995).
18. Winzer-Serhan UH, Raymon HK, Roide RS et al. Neuroscience 76, 261-272 (1997).
19. Simmons DM, Arriza JL and Swanson LW. J Histotechnol 12, 169-181 (1989).
20. Cox KH, DeLeon DV, Angerer LM and Angerer RC. Dev Biol 101, 485-502 (1984).
21. Winzer-Serhan UH, Broide RS, Chen Y and Leslie FM. Brain Res Protoc 3, 229-241 (1999).
22. Young WS III and Kuhar MJ. Proc Natl Acad Sci USA 77, 1696-1700 (1980).
23. Unnerstall JR, Kopajtic TA and Kuhar MJ. Brain Res Rev 7, 69-101 (1984).
24. Monroe PJ, Smith DL and Smith DJ. Ann NY Acad Sci 763, 497-500 (1995).
25. Ruggiero DA, Regunathan S, Wang H et al. Ann NY Acad Sci 763, 208-221 (1995).
26. Broadhurst AM, Alexander BS and Wood MD. Life Sci 43, 83-92 (1988).
27. De Vos H, Convents A, De Keyser J et al. Brain Res 566, 13-20 (1991).
28. Wikberg JE. Pharmacol Toxicol 64, 152-155 (1989).
29. Uhlén S and Wikberg JE. Pharmacol Toxicol 69, 341-360 (1991).
30. Rosin DL, Zeng D, Stonetta RL et al. Neuroscience 56, 139-155 (1993).
31. Rosin DL, Talley EM, Lee A et al. J Comp Neurol 372, 135-165 (1996).
32. Stone LS, Broberger C, Vulchanova L et al. J Neurosci 18, 5928-5937 (1998).
33. Howe JR, Yaksh TL and Go VL. Neuroscience 21, 385-394 (1987).